The Surprising Benefits of Red Light (Economist)

Summary

A survey of photobiomodulation (PBM) — therapy with red and near-infrared light — from a clinically established use (healing chemotherapy mouth ulcers) through early human studies (retina, blood glucose) to speculative ones (brain and spinal-cord injury, Parkinson's, Alzheimer's, psychiatric disorders). The proposed mechanism is mitochondrial: long wavelengths penetrate tissue and reactivate cytochrome c oxidase, raising ATP output and antioxidant enzymes. The article's second half is a warning: the "wellness" market selling masks, blankets and saunas runs ahead of the evidence, and dosage (distance, wavelength, exposure time) is routinely ignored.

Key claims, with the populations and doses attached

• Oral mucositis: red LEDs placed in the mouth of patients with radiation/chemotherapy mouth ulcers improve symptoms in more than half of cases (no trial named).
• Retina (Jeffery et al., 2020, Journals of Gerontology A, pilot): 24 volunteers aged 28–72 looked into a 670 nm torch for 3 minutes a day for 2 weeks; those over 40 improved colour-contrast sensitivity by an average of ~20%, no effect in younger participants. Jeffery's rationale: retinal ATP falls ~70% over a lifetime. Article: "further investigations will be needed before such results can turn into treatments".
• Blood glucose (Powner & Jeffery, 2024, Journal of Biophotonics, RCT): 30 healthy, non-diabetic adults; 15 got 15 minutes of 670 nm red light on the back (so they could not see it), 15 a dummy exposure, before a sugary drink. Peak glucose was 7.5% lower in the light group (the paper also reports a 27.7% lower integrated rise over 2 hours; the Economist quotes only the peak figure). The authors themselves flag that a warming-driven blood-flow change has not been excluded.
• Brain and spinal-cord injury (Davies, University of Birmingham): an implantable silicone LED device, patent applied for, to be tested in pigs next; cell-culture and rodent experiments showed ≥20% reductions in cell death in the days after injury. No human data.
• Neurodegeneration and psychiatry: Parkinson's and Alzheimer's are linked to the oxidative stress PBM is meant to relieve; "early-stage research" only.
• Physiotherapy and post-operative recovery: reduced inflammation, better circulation, less pain in tendon/muscle/joint injuries (no studies cited).

What is flagged as unproven or problematic

• Commercial interests have "coloured many research outcomes" — small samples, missing control groups.
• Dose is mostly ignored: source distance, wavelength, device power and exposure length all change outcomes, and more is not better — overexposure causes a metabolic "traffic jam" and ATP falls.
• The sun-exposure framing (windows block infrared, LED offices over-supply blue) is Jeffery's reckoning, with "how far those effects stretch" unknown. His one practical line: ~20 minutes outdoors several times a day supplies all the red light a healthy person needs.

Wikilinks

Photobiomodulation — concept page: mechanism, evidence tiers, dosage problem. Skin Ageing and Retinoids — dermatologists already use red light for skin ageing; both pages share the "wellness claims vs evidence" theme. Type 2 Diabetes Remission — the glucose study was in non-diabetic volunteers; any link to diabetes is the authors' hint, not a finding. The Economist — Science & technology.

Captured-by trigger

Source file: raw/processed/Economist 2026-07-25 Science---Techn - The surprising benefits of red light.md.